Vimarsana
Biggest News Aggregation in the World

Eluting Stent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eluting Stent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eluting Stent Today - Breaking & Trending Today

Global Drug Eluting Stent Market Size, Share & Trends Analysis Report 2023-2030 - ResearchAndMarkets.com - Vimarsana News

Global Drug Eluting Stent Market Size, Share & Trends Analysis Report 2023-2030 - ResearchAndMarkets.com

DUBLIN — The

Global Coronary Stents Industry on Track to Achieve US$51.2 Million Valuation by 2032 with 5.1% CAGR - Vimarsana News

Global Coronary Stents Industry on Track to Achieve US$51.2 Million Valuation by 2032 with 5.1% CAGR

The Global Coronary Stents Industry is on a trajectory to attain a significant valuation of US$ 51.2 million by the year 2032, exhibiting a steady compound annual growth rate (CAGR) of 5.1% from 2022 to 2032. In 2022, the market is expected to hit an estimated value of US$ 33.36 million.The market’s growth is primar...

United States ENT & Bronchoscopy Devices Market Analysis - Vimarsana News

United States ENT & Bronchoscopy Devices Market Analysis

Dublin, June 27, 2023 (GLOBE NEWSWIRE) -- The "United States ENT & Bronchoscopy Devices Market Size, Share, & COVID-19 Impact Analysis 2023-2029...

Elixir Medical Corporation: EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical's DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES) - Vimarsana News

Elixir Medical Corporation: EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical's DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)

First head-to-head randomized clinical trial (RCT) of DynamX Bioadaptor compared to Resolute Onyx DES shows statistically significant effectiveness in restoring vessel pulsatility, achieving significantly

By 2032 expects the Coronary Stents Market is projected to reach US$ 51.2 Million at a CAGR of 5.1 % - Vimarsana News

By 2032 expects the Coronary Stents Market is projected to reach US$ 51.2 Million at a CAGR of 5.1 %

The global Coronary Stents Market is expected to reach a valuation of US$ 51.2 Million by 2032 while the market expands at a moderate CAGR of 5.1% during 2022 to 2032. In 2022, the target market will reach an estimated value of US$ 33.36 Million. Owing to the rising geriatric population as well as the increasing pre...